Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  allogeneic cytomegalovirus-specific cytotoxic T lymphocytes
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients with a Persistent Cytomegalovirus Infection
Status: Active
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: 2013-0657, NCI-2014-01990, NCT02210078
Donor Cytomegalovirus-Specific Cytotoxic T Lymphocytes in Treating Patients Undergoing Donor Stem Cell Transplant
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00013947, NCI-2013-00579, NCT01274377
Study of Allogeneic EBV-CTLs in EBV-Associated Viremia or Malignancies
Status: Active
Phase: No phase specified
Type: Treatment
Age: Any age
Trial IDs: EBV-CTL-201, NCI-2016-01279, NCT02822495
Start Over